NorthWest Biotherapeutics Inc (NWBO)

[Gus McCrae]

Thank you so much for sharing that. This seems to be confirmation that they chose to withhold TLD until a journal publication due to their concerns about TLD's affect on the stock price absent a journal article. Let me know if you think I'm taking his statement too far...I know it's just a piece of whatever your conversation was and may not actually be a fair representation.

For the moment at least, I'm going to imagine that their concerns are about releasing TLD and sustaining a stock price of $4.00 or more for 3 months in order to qualify for uplisting, rather than their concerns that if they release TLD without a journal, the stock price would fall below $1.00 or something like that.